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During the activation of complement C4 to C4b, the exposure of its thioester domain
(TED) is crucial for the attachment of C4b to activator surfaces. In the C4b crystal struc-
ture, TED forms an Arg104–Glu1032 salt bridge to tether its neighbouring macroglobulin
(MG1) domain. Here, we examined the C4b domain structure to test whether this salt
bridge affects its conformation. Dual polarisation interferometry of C4b immobilised at a
sensor surface showed that the maximum thickness of C4b increased by 0.46 nm with
an increase in NaCl concentration from 50 to 175 mM NaCl. Analytical ultracentrifugation
showed that the sedimentation coefﬁcient s20,w of monomeric C4b of 8.41 S in 50 mM
NaCl buffer decreased to 7.98 S in 137 mM NaCl buffer, indicating that C4b became
more extended. Small angle X-ray scattering reported similar RG values of 4.89–4.90 nm
for C4b in 137–250 mM NaCl. Atomistic scattering modelling of the C4b conformation
showed that TED and the MG1 domain were separated by 4.7 nm in 137–250 mM NaCl
and this is greater than that of 4.0 nm in the C4b crystal structure. Our data reveal that in
low NaCl concentrations, both at surfaces and in solution, C4b forms compact TED–MG1
structures. In solution, physiologically relevant NaCl concentrations lead to the separation
of the TED and MG1 domain, making C4b less capable of binding to its complement reg-
ulators. These conformational changes are similar to those seen previously for comple-
ment C3b, conﬁrming the importance of this salt bridge for regulating both C4b and C3b.
Introduction
In the complement system of innate immunity, its activation through the classical and lectin pathways
through C4b is distinct from its activation in the alternative pathway through C3b. The classical
pathway requires binding of C1q to antibody–antigen complexes on pathogen surfaces, whereupon
the serine protease C1r2C1s2 is activated [1]. The lectin pathway involves the interaction of mannose-
binding lectin to mannose residues on pathogen surfaces, whereupon mannose-binding lectin-asso-
ciated serine protease (MASP)-1 and MASP-2 are activated [1]. These activated proteases cleave com-
plement C4 (205 kDa) into C4a (9 kDa) and C4b (188 kDa). Recent crystal structures for C4 and C4b
provided high-resolution information on their structures and functions [2,3]. C4 and C4b possess 13
and 12 domains, respectively, including a core of eight macroglobulin domains (MG1–MG8). The
cleavage of the C4a fragment (the anaphylatoxin domain) from C4 results in a large conformational
change in its domain structure, in which the thioester domain (TED) moves away from its buried pos-
ition in C4 next to the MG8 domain to make contact with the MG1 domain (Figure 1A). By this, a
salt-bridge interaction between Arg104–Glu1032 is formed, and the reactive thioester bond within the
TED is exposed for nucleophilic attack on its targets. Activated C4b is thus capable of attaching cova-
lently to hydroxyl or amine groups on pathogenic surfaces, thus acting as an opsonin.
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Complement C4 is structurally homologous to complement C3 in the alternative pathway and to comple-
ment C5, all three of which belong to the α2 macroglobulin (α2M) superfamily with similar domain structures
[4]. The same large conformational change in TED occurs between inactive complement C3 and its activated
form C3b [5,6]. In C3, TED is partly buried in contact with the MG8 domain. In C3b, TED and the MG1
domain make contact with each other through an Arg102(MG1)–Glu1032(TED) salt bridge (Figure 1B). In con-
trast, even though inactive C5 showed the same buried TED–MG8 arrangement seen in C3 and C4 [7], the
crystal structure of C5b in its complex with C6 showed that its TED and MG1 domains were separated by up
to 5 nm and were not in contact (Figure 1C) [8]. Protein crystal growth requires non-physiological conditions
such as low or high salt concentrations, and these may induce non-native protein conformations within the
crystal lattice. The ﬁrst evidence of different conformations for TED in C3b came from solution structural ana-
lyses of C3u, the thioester-hydrolysed form of C3, which has C3b-like functional properties [9]. Different con-
formations in C3u were revealed by analytical ultracentrifugation (AUC) and small angle X-ray scattering
(SAXS) performed in low salt (50 mM NaCl) and physiological salt (137 mM NaCl). These corresponded to a
compact TED–MG1 conformation in low salt and an extended TED–MG1 arrangement in physiological salt.
Solution structures for C3b in low and physiological salt also showed the same outcome by AUC and SAXS
[10]. For C3b, mutagenesis established that the compact structure was stabilised by the Arg102(MG1)–
Glu1032(TED) salt bridge. In the C3S wild-type allotype of C3b, this bridge was formed in low salt, but became
dissociated in physiological salt (Figure 1B) [10]. This weakly formed salt bridge is important for C3b regula-
tion by its cofactor Factor H, because this salt bridge stabilised the interaction with Factor H. In the C3F
disease-risk allotype, when Arg102 is replaced by Gly102, this salt bridge is no longer possible and C3b is now
resistant to Factor H-mediated degradation. C3F is associated with blindness through age-related macular
degeneration (AMD) and renal failure through atypical haemolytic uraemic syndrome (aHUS) [11].
In C4b, the corresponding salt-bridge residues were seen to be Arg104(MG1) and Glu1032(TED) (Figure 1A).
Because of the importance of this salt bridge for C3b and C4b regulation in the three pathways for complement
activation, we set out to determine whether C4b presented a compact solution conformation in low salt and an
extended one in physiological salt. In low NaCl concentration conditions, the salt-bridge interaction between
Arg104–Glu1032 in C4b would be promoted [12]. In addition, given that activated C4b binds to surfaces, it is
not known whether these key conformational changes in TED would still occur if C4b were to be bound to a
surface. Here, dual polarisation interferometry (DPI) was employed as a sensitive sensor technique that
Figure 1. Crystal structures of human C4b and C3b.
(A) The α, β and γ chains of C4b in its crystal structure (PDB ID: 4XAM) are shown in green, cyan and pink, respectively. The
biotinylation site at Cys991 in the thioester bond of TED is shown as red spheres. The length and width of C4b are indicated
on its z-axis and x-axis as shown. Inset: The Arg104–Glu1032 salt bridge between TED (cyan) and the MG1 domain (green).
(B) The α and β chains of C3b in its crystal structure (PDB ID: 2I07) are shown as green and cyan, respectively. Inset: the
Arg102–Glu1032 salt bridge between TED (cyan) and the MG1 domain (green). (C) Schematic cartoon of the 12 domains in C4b.
The MG1–MG8, C345C and TED/CUB domains are in green, purple and blue, respectively. For the scattering ﬁts, linkers
1 and 4 connect the CUB–MG8 domains, and linkers 2 and 3 connect the TED–CUB domains.
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measures mass and thickness changes in C4b deposited onto a chip [13]. For example, DPI was shown to
detect thickness changes as low as 0.1 nm when calcium ions bind to transglutaminase [14]. AUC monitors
size and shape changes of macromolecules in solution [15], and was here used to study monomeric C4b, inde-
pendently of any effects caused by C4b dimerisation. SAXS resulted in solution structural data for C4b in dif-
ferent NaCl concentrations [16]. The SAXS data enabled the application of a new advanced modelling method
to create physically realistic atomistic C4b conformations for comparison with the experimental SAXS curves
[17]. These deﬁned the TED–MG1 separation. The three experimental analyses and their atomistic modelling
showed for the ﬁrst time that C4b is seen to form a compact structure in low NaCl concentrations and more
extended structures in physiological or high NaCl concentrations, in turn showing that TED is conformation-
ally mobile as a function of the NaCl concentration. This outcome conﬁrmed that both C4b and C3b under-
went the same conformational change with the TED domain in low and physiological salt.
Materials and methods
Puriﬁcation of C4b
C4 was isolated from outdated human plasma obtained from the blood transfusion unit, University College
London Hospital, using slight modiﬁcations of the published method [18]. Human plasma was dialysed into
running buffer containing 85% Buffer A (20 mM HEPES, 50 mM ε-aminocaproic acid, 5 mM EDTA·Na2, pH
7.4) and 15% Buffer B (as for Buffer A, but including 1 M NaCl) and left overnight at 4°C. The plasma was
spun down (Beckman Coulter, Avanti J-30J) to remove precipitates at 11k r.p.m. for 15 min. Supernatant
Figure 2. Puriﬁcation of C4 and C4b.
(A) Elution proﬁle of C4 from the HiTrap Heparin HP column. C4 was eluted as peak A, being separately resolved from the
α-trypsin inhibitor (peak B). (B) Reducing SDS–PAGE analysis of the Heparin HP elution. Lane 1, Mark 12™ molecular mass
standard; Lane 2, C4-containing pool before application to the heparin column; Lane 3, ﬂow-through from heparin column;
Lanes 5 and 6, peak A showing the α, β and γ chains of C4; Lanes 7–10, peak B showing the bands from α-trypsin inhibitor
and C4. (C) Gel ﬁltration elution proﬁle of C4b from Superose 6™. (D) SDS–PAGE analysis of C4b and C4. Lane 1, Mark 12™
molecular mass standards; Lanes 2 and 3, non-reduced and reduced C4b, respectively, before gel ﬁltration; Lanes 4 and 5,
non-reduced and reduced C4b, respectively, after gel ﬁltration, showing the intact protein and its α0, β and γ chains,
respectively; Lanes 6 and 7, non-reduced and reduced C4 before the heparin column stage. The α and β chains of C4b are
indicated; the α-band shifts to α0 on activation of C4 to C4b. The HSA contaminant is human serum albumin.
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(10 ml) was loaded onto a 20 ml Q-Sepharose fast ﬂow anion exchange column (Amersham Biosciences) for
separations based on isoelectric points. Non-speciﬁcally bound proteins were ﬁrst eluted with ﬁve column
volumes of running buffer. Next, C4 was eluted using a 200 ml linear salt gradient from 150 to 500 mM NaCl.
Reducing SDS–PAGE (10%) conﬁrmed the presence of the α-chain (97 kDa), β-chain (75 kDa) and γ-chain
(33 kDa) (not shown). The C4 fractions eluted between 300 and 350 mM NaCl were dialysed against running
buffer for the Mono Q 5/50 GL ion exchange column (GE Healthcare). C4 fractions (20 ml) were loaded for
elution using a salt gradient from 150 to 500 mM NaCl. C4 eluted at 380 mM NaCl and the fractions were
checked by reducing SDS–PAGE (10%) to conﬁrm the presence of intact C4 from the α, β and γ bands (not
shown). The contaminant α-trypsin inhibitor (222 kDa) was removed by passing the C4 fractions through a
5 ml HiTrap Heparin HP column pre-equilibrated with Buffer C (50 mM Tris–HCl, 90 mM NaCl and 0.5 mM
EDTA, pH 7.4) (Figure 2A) [19]. The ﬂow-through with some C4 was collected for reuse, and the column was
washed with one volume of Buffer C. Bound C4 was eluted using 35 ml of a linear salt gradient from 90 mM
to 1 M NaCl. C4 eluted between 170 and 230 mM NaCl (lane 6, Figure 2B), and an α-trypsin inhibitor was
eluted between 250 and 400 mM NaCl (lanes 9 and 10, Figure 2B).
C4b was produced by treating 1 mg/ml C4 in HEPES buffer (10 mM HEPES, 137 mM NaCl and 0.5 mM
EDTA, pH 7.4) with 20 mg of activated C1s (Complement Tech, U.S.A.) for 60 min at 37°C. The reaction was
stopped by adding 0.5 mM diisopropyl ﬂuorophosphate. For AUC and SAXS experiments, the reactive thioester
group was blocked with 20 mM iodoacetamide, which was added to the mixture and incubated in the dark at
20°C for 30 min. To make biotinylated C4b for DPI experiments, 1 mg of the maleimide–PEG-2–biotin linker
(Thermo Fisher Scientiﬁc) was added to the mixture instead of iodoacetamide and incubated for 1 h. An excess
biotin linker was removed by dialysis of C4b against HEPES buffer overnight. Finally, the iodoacetamide-treated
C4b or biotinylated C4b was concentrated and passed through a Superose™ 6 prep grade XK 16/60
size-exclusion column shortly prior to experiments to remove aggregates (Figure 2C). SDS–PAGE conﬁrmed
the presence of C4b (lane 5, Figure 2D) and not C4 (lane 7, Figure 2D).
DPI measurements of C4b
To measure the physical parameters of a layer deposited on the surface of a sensor chip, the AnaLight® Bio200
dual-polarization interferometer (Farﬁeld Sensor Ltd, Salford, U.K.) was used [13]. A DPI sensor chip consists
of two waveguides stacked one on top of each other. The upper waveguide is exposed to changes from biomole-
cular interactions and is the sensing waveguide upon which the sample and reference channels (15 mm ×
1 mm) are mounted. The lower waveguide is the reference waveguide with a constant refractive index. Two
polarisations of laser light (transverse magnetic TM and transverse electric TE) are used to detect changes in
protein binding. As proteins are added to the sample and reference channels on the sensor waveguide, the
effective refractive index of the sensor waveguide is changed for each polarisation (TE and TM). These lead to
phase changes in the interference patterns generated by the sensing and reference waveguides, and enable the
thickness and mass of the added layer to be resolved mathematically [20].
An amine AnaChip® was used for the DPI experiments. The free amine groups on the waveguide surface
were modiﬁed by a NHS–PEG4–biotin linker [2 mg in 500 ml of phosphate-buffered saline (PBS; 137 mM
NaCl, 8.1 mM Na2HPO4, 2.7 mM KCl and 1.5 mM KH2PO4, pH 7.4); Thermo/Fisher Scientiﬁc,
Loughborough, U.K.]. An NHS–PEG4–biotin linker (200 ml) was placed on top of the sample and reference
channels and left for 2 hours. Excess PBS was washed off with deionised water and the sensor chip left to dry.
The prepared chip was then inserted into the DPI machine. The sensor chip structure and the refractive index
of the running buffer (10 mM HEPES and 50 mM NaCl, pH 7.4) were calibrated using both 80% (w/w)
ethanol/water and water before the experiment, and the linearity of the phase measurement was calibrated from
the ethanol to water transition using the Analight® analysis software. Experimental measurements were made at
20°C with a ﬂow rate of 50 ml/min. HEPES buffers with six NaCl concentrations from 75 to 250 mM were
injected over the bare surface. The responses were recorded and used to calibrate the refractive indices of the
salt solutions. NeutrAvidin (40 mg/ml) was immobilised onto the biotin surface at a ﬂow rate of 60 ml/min, fol-
lowed by rinsing of the surface with 10 mM HEPES and 2 M NaCl, pH 7.4, buffer at a ﬂow rate of 50 ml/min
for 2 min. HEPES buffer with the six different NaCl concentrations was then injected over the NeutrAvidin
surface and the responses were recorded. Once the baseline stabilised, 120 ml of biotinylated C4b (30 mg/ml)
was injected over the sample channel on top of the NeutrAvidin layer at a ﬂow rate of 20 ml/min. After stabil-
isation, the NaCl solutions were injected once more to probe the C4b structure. The mass, thickness and
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density changes for the NeutrAvidin and C4b layers during each buffer injection were calculated from the raw
data using the Analight® analysis software (Farﬁeld Sensors Ltd, Salford, U.K.).
AUC measurements of C4b
AUC sedimentation velocity data for C4b were collected on two Beckman XL-I analytical ultracentrifuges
(Beckman Coulter, Inc., Palo Alto, CA) [15]. A total of 130 absorbance and interference scans were acquired in
sedimentation velocity experiments at 20°C with rotor speeds of 50 000 r.p.m. in two-sector cells with a column
height of 12 mm. C4b was dialysed into 10 mM HEPES containing 50 or 137 mM NaCl, pH 7.4. The C4b con-
centrations were 0.25, 0.5, 0.75 and 1.0 mg/ml. The buffer density was measured using an Anton-Paar DMA
5000 density meter to be 1.00487 and 1.00195 g/ml for the 137 and 50 mM NaCl buffers, respectively. SEDFIT
version 14.6 was used to ﬁt the experimental boundaries directly according to the Lamm equation [21].
Size-distribution analyses c(s) were produced by SEDFIT that assumed that all species have the same frictional
ratio f/fo. The ﬁnal SEDFIT analyses used a ﬁxed resolution of 200, and the c(s) ﬁt was optimised by ﬂoating
the meniscus and the cell bottom until the root mean square deviations and the ﬁt became satisfactory. The f/fo
value used was held at 1.45 to follow that used in the C3b study [10] and this is insensitive to the shape and
mass changes being observed. The C4b concentrations were determined using an absorption coefﬁcient of 9.5
(1% concentration, wavelength 280 nm and 1 cm path length) calculated from its composition (UNIPROT code
P0C0L4 for the C4A allotype), assuming the presence of four oligomannose and complex-type oligosaccharides
at Asn207 (β-chain) and at Asn843, Asn1309 and Asn1372 (α-chain) [22,23]. The sequence-predicted molecu-
lar masses of C4 and C4b (including four N-glycan chains) were 200.5 and 188.0 kDa, respectively. A partial
speciﬁc volume of 0.736 ml/g was calculated for C4b from its composition [24].
SAXS measurements of C4b
SAXS data for C4b in three different NaCl concentrations were obtained on the BioSAXS robot at the BM29
beamline at European Synchrotron Radiation Facility, Grenoble, France (ESRF) [25,26]. The data were collected
in 16-bunch mode using beam currents from 65 to 78 mA. Data were recorded using a CMOS hybrid pixel
Pilatus 1 M detector with a resolution of 981 × 1043 pixels (pixel size of 172 mm× 172 mm). The sample
detector distance was 3.0 m. The C4b concentrations were 0.6, 0.8, 1.0 and 1.2 mg/ml. An exposure time of 1 s/
frame was used and radiation damage was not observed in the 10 time frames of each SAXS run.
In a given solute–solvent contrast, the radius of gyration RG corresponds to the mean square distance of
scattering elements from their centre of gravity and is a measure of structural elongation. Guinier analyses of
the I(Q) curves at low scattering vectors Q (where Q = 4π sin θ/λ; 2θ is the scattering angle and λ is the wave-
length) give the RG value and the forward scattering at zero angle I(0) from the expression [27]:
ln I(Q) ¼ ln I(0) R2G Q2=3
This expression is valid in a Q·RG range up to 1.5. The RG analyses utilised SCT software on Linux worksta-
tions [28]. Indirect transformation of the I(Q) curve measured in reciprocal space into real space gives the dis-
tance distribution function P(r) and was carried out using the program GNOM [29]:
P(r) ¼ 1
2p2
ð1
0
I(Q)Qr sin(Qr) dQ
P(r) corresponds to the distribution of distances r between volume elements and gives an alternative calculation
of the RG and I(0) values based on the full scattering curve I(Q). It also gives the most frequently occurring dis-
tance M and the maximum dimension of the macromolecule L.
Atomistic modelling of the C4b solution structure
Using the recent C4b crystal structure (PDB ID: 4XAM) [3] as a starting structure, molecular Monte Carlo
simulations performed using the SASSIE suite [30] were used to generate a library of 21 000 conformationally
varied and physically realistic atomistic C4b models for comparison with the SAXS data. Prior to this simula-
tion, the crystal structure was parametrised in the CHARMM36 force ﬁeld (including the addition of hydrogen
atoms) through the PDB reader component of CHARMM-GUI [31–33]. This parametrised model was then
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subjected to energy minimisation to remove steric overlaps. The Monte Carlo simulation proceeded by sam-
pling the ψ and φ backbone dihedral angles of deﬁned ﬂexible protein linkers (Figure 1C). One strand ran from
the MG1–MG8 core to the TED (Linker 1 and Linker 2), and the other returned from TED back to the MG
core (Linker 3 and Linker 4). The linker sequences in that order were E933KEGA937, P984LDLG989,
T1322EERG1326 and V1387LDMKNTTC1394. Models were generated by varying Linker 1 and Linker 2 using the
complex Monte Carlo module of SASSIE. In each Monte Carlo move, all residues after the last residue of
Linker 1 [including both the CUB (C1r/C1s–UEGF–BMP1) domain and the TED] or Linker 2 (TED only)
were moved. To retain the correct conformation to the rest of C4b, the returning strands were severed at the
ends of Linker 3 and Linker 4. To prevent the sampling of non-physical conformations of C4b, distance con-
straints of 1.4 and 2.3 nm were placed between the ﬁrst and last residues in each of Linker 3 and Linker 4,
respectively. These constraints replicated the linker lengths seen in the C4b crystal structure [3]. Three con-
formational ensembles were generated: (i) only Linker 1 was varied, creating 10 000 conformers of C4b in
which both the CUB domain and the TED moved as one ﬁxed entity; (ii) only Linker 2 was varied, resulting in
2000 conformers with the CUB domain held ﬁxed in the position observed in the C4b crystal structure, but
with variable TED positions and (iii) only Linker 2 was varied, but this time using the best-ﬁt CUB domain
position from the ﬁrst ensemble to create 9000 conformers. A steric overlap between the 11 C4b domains
(Figure 1C) was excluded by SASSIE. Theoretical scattering curves were generated for the resulting 21 000 C4b
conformers using SCT [28], for comparison with the experimental SAXS curves. A cube of side length of
0.540 nm in combination with a cut-off of four atoms was used to convert the C4b atomic co-ordinates into
Debye sphere models. The sphere models corresponded to the unhydrated structures. In SAXS experiments, a
hydration shell containing 0.3 g of H2O/g of protein is visible [34]; hydration spheres were added in SCT to
replicate this. SCT compared the theoretical scattering from each model to the experimental curves, with the
quality of ﬁt quantiﬁed using the R-factor:
R-factor ¼
P j jIExpt(Q) j  h jITheor(Q)j jj jP jIExpt(Q) j
where IExpt(Q) represents the experimental data at each Q value, ITheor(Q) represents the theoretical values and
η the scaling factor necessary to compare them. RG values were calculated from the modelled curves in the
same Q ranges used for the experimental Guinier RG ﬁts. The best-ﬁt models were selected using both the
lowest R-factor and passing an RG ﬁlter of ±5% of the experimental value. The 100 best-ﬁt atomistic models
from each of the 137 and 250 mM NaCl analyses are available in Supplementary Material.
Sedimentation coefﬁcients s20,w for the C4b crystal structure and best-ﬁt scattering models were calculated
directly from the atomic coordinates using the HYDROPRO shell-modelling program [35]. The default value
of 0.31 nm for the atomic element radius for all atoms was used to represent the hydration shell.
Results
Puriﬁcation of C4b
For biophysical measurements, C4b was prepared from puriﬁed C4. Human C4 and C4u (the thioester-
hydrolysed form of C4) from outdated human plasma were separated on an MonoQ column, where C4u was
eluted at 300 mM NaCl and C4 at 380 mM NaCl (not shown). In addition, α-trypsin inhibitor co-puriﬁed with
C4 [18] and was removed using a heparin column (see Materials and Methods). C4 and α-trypsin inhibitor
were eluted as separate peaks (Figure 2A,B). Finally, after C1s cleavage of C4, C4b was eluted as a single sym-
metrical peak from a Superose 6™ gel ﬁltration column (Figure 2C). Reducing (4–12%) SDS–PAGE conﬁrmed
the presence of intact C4b α0, β and γ bands, in distinction to the bands seen for C4 where the α-band showed
a different mass (lanes 5 and 7, Figure 2D).
DPI analyses of immobilised C4b
DPI measures the interaction between biomolecules in real time without the use of chemical tags by monitoring
simultaneously the thickness, mass and density of a biological layer deposited on the surface of a sensor chip
[13]. In the DPI instrument, this is achieved by the use of a sensing waveguide and a reference waveguide
within the sensor chip, upon which a laser beam with two polarisations TE and TM is focused along its length
(see Materials and Methods). Following the injection of NeutrAvidin (40 mg/ml) over the biotinylated surface
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of the sensing waveguide, the combined changes in the TE and TM polarisations (Figure 3) indicated a unique
solution that showed a thickness increase of 7.5 nm, a mass increase mL of 3.1 ng/mm
2 and an average density
of 0.416 g/cm3 (not shown). From these, the surface area A per NeutrAvidin molecule was calculated to be
32 nm2/molecule (5.7 nm × 5.7 nm/molecule) from the expression A =Mw/(NA mL) [36], where Mw is the
molecular mass of NeutrAvidin (60 kDa) and NA is Avogadro’s number. The area per molecule, in conjunction
with the layer thickness, shows whether a single layer or a multilayer structure has been formed. If A is signiﬁ-
cantly lower than the theoretical saturated value, this indicates a multilayer structure. The maximum theoretical
area for NeutrAvidin is 24.6 nm2/molecule (radius 2.8 nm, measured from the crystal structure of avidin) [37].
Figure 3. The DPI raw output for the immobilisation of biotinylated C4b on a NeutrAvidin-coated surface.
NeutrAvidin was ﬁrst ﬂowed over a biotinylated sensor chip at ∼8000 s, followed by biotinylated C4b after ∼12 000 s. The TE
and TM polarisations (red and black, respectively) increase between the immobilisations of NeutrAvidin and biotinylated C4b.
The TE and TM changes with the six buffer injections from 75 to 250 mM NaCl (each separated by the running buffer in 50 mM
NaCl) are visible as six peaks.
Figure 4. The thickness, mass and density changes for C4b with increase in NaCl by DPI.
(A–C) The thickness, mass and density changes, respectively, show the difference between the immobilised NeutrAvidin and
C4b layers with an increase in the NaCl concentration. Error bars based on a maximum 5 mrad phase error are shown when
visible. (D) Postulated movement of the MG1–MG8 core in C4b (not drawn to scale) bound to the NeutraAvidin layer in the
presence of different NaCl buffers. The loss of the Arg104–Glu1032 salt bridge (Figure 1A) causes TED (cyan) and the MG (green)
domains to move apart in high NaCl concentration.
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The agreement between the experimental and theoretical areas per molecule indicated that NeutrAvidin has
formed a monolayer surface. Successive increases in NaCl concentration were made in the DPI experiment,
resulting in the TM and TE response data for the NeutrAvidin layer (Figure 3). The thickness, mass and density
values in 50 mM NaCl buffer were set as baselines (Figure 4). Successive buffer injections (75–250 mM NaCl)
showed no signiﬁcant thickness increase (Figure 4A). This lack of change indicated that the increase in NaCl
concentration had no effect on the NeutrAvidin layer (Figure 4B). This absence of structural changes showed
that NeutrAvidin was a suitable base layer for the present study.
Complement C4b was immobilised on the NeutrAvidin-coated sensor surface in its physiological orientation
by labelling its free exposed thiol group with biotin (Figure 1A) [38]. The TM and TE response data for the C4b
injection onto the NeutrAvidin layer occurred at 12 500 s (Figure 3). The observed thickness increase of 7.6 nm
in 50 mM NaCl indicated that C4b formed a separate layer on top of the NeutrAvidin layer with a mass
increase mL of 1.93 ng/mm
2 and an average protein density of 0.255 g/cm3. The experimental area A per C4b
molecule was 162 nm2/molecule (12.7 nm × 12.7 nm/molecule). The theoretical saturated area per molecule
value was 63.6 nm2 (radius 4.5 nm) from the x-axis of its crystal structure (Figure 1A) [3]. Taking the molecu-
lar mass of C4b to be 188 kDa, the increase in mL showed that the molar ratio between C4b and NeutrAvidin
was 1:5, showing that one C4b molecule was immobilised for every ﬁve NeutrAvidin molecules. This ratio
agreed well with that of the experimental areas per molecule of 31 and 154 nm2/molecule for NeutrAvidin and
C4b, respectively. The lower density of immobilised C4b also indicated that fewer C4b molecules were bound
on top of the NeutrAvidin layer. Moreover, the increase in thickness of 7.6 nm suggested that bound C4b had
adopted a tilted orientation on the NeutrAvidin surface (Figure 4A); the maximum possible increase in the
thickness was expected to be 15 nm from the maximum length of the C4b crystal structure along its z-axis
(Figure 1A).
To determine the dependence of the C4b structure on different NaCl concentration, six buffers with
increased NaCl concentrations were injected over the surface (Figure 3). To determine the changes arising from
C4b alone, the observed thickness, mass and density values were subtracted from those for the NeutrAvidin
surface, since no changes were observed for NeutrAvidin (see above). The thickness and density proﬁle changes
for immobilised C4b were signiﬁcantly different from those for NeutrAvidin alone (Figure 4A,C). However, the
mass change proﬁle for C4b was similar to that for NeutrAvidin (Figure 4B). The thickness change for C4b
gradually increased as the NaCl concentration increased, with the biggest increase occurring between 75 and
100 mM NaCl (Figure 4A). Above 100 mM NaCl, the thickness change showed an increase of 0.34 nm within
error, and this is the mean of the ﬁve values observed for C4b, calculated as a distinct layer between 100 and
250 mM NaCl. Because the C4b mass change was unchanged (Figure 4B), the density of the C4b layer
decreased compared for that for NeutrAvidin (Figure 4C). The thickness change showed that the increase in
NaCl concentration induced conformational changes of C4b, such that C4b became more extended in its con-
formation in high NaCl concentrations. The changes are schematically shown in Figure 4D. While the precision
of the DPI measurements was at best ∼0.01 nm [39], the maximum possible combined error in the phase
change in this experiment was estimated from the phase calibration (linearisation) to be 5 mrad [i.e. 0.04% of
the phase change and mass signal for NeutrAvidin or 0.5% for the calculated thickness (0.039 nm) and 1.4%
(0.107 nm) for the thickness of C4b]. This was used to calculate the error bars shown in Figure 4A–C.
AUC analyses of C4b in solution
The sedimentation coefﬁcient s20,w monitors the rate of sedimentation of C4b in solution through an AUC cell
and is dependent on the shape and molecular mass of C4b [15]. The AUC analyses provide shape information
on C4b in solution, in distinction to that obtained for C4b immobilised on surfaces. Sedimentation velocity
experiments were performed using four C4b concentrations between 0.25 and 1.0 mg/ml (1.3–5.3 mM) in each
of 50 and 137 mM NaCl buffers. This concentration range is comparable to the plasma concentration of C4
which is 0.24 mg/ml, while being less than that of 1.15 mg/ml for C3 [40]. The peaks in the size-distribution
analyses c(s) monitor the extent of sample monodispersity, and the shape is monitored through the sedimenta-
tion coefﬁcient s20,w of the observed peaks [21]. Data analyses resulted in good boundary ﬁts for C4b using
both absorbance and interference optics (left panels, Figure 5). A major peak was visible at all C4b concentra-
tions in 50 and 137 mM NaCl buffers, together with a minor peak at higher S values.
(i) In 137 mM NaCl, the major monomeric peak for C4b showed s20,w values of 7.98 ± 0.08 and 7.97 ± 0.07 S,
respectively, for the absorbance and interference data, respectively (Figure 5A,C). The molecular masses
derived from the c(s) peaks seen by SEDFIT corresponded to 185 kDa, which agreed well with the expected
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monomer molecular mass of C4b of 188 kDa calculated from its sequence-determined composition. The s20,w
values showed no concentration dependence, indicating that both the shape and size of C4b were unchanged
with different protein concentrations. The minor peak observed at 11.5 S gave a molecular mass of 312 kDa
from SEDFIT, which was comparable to the expected value of 376 kDa for a dimer. The lower than expected
mass value is most likely to arise from exchange between the monomer and the presumed dimer, but noting
that the existence of C4b trimer or tetramer by this approach cannot be deﬁnitively ruled out. Peak integration
showed that the proportion of the presumed C4b dimer was 9 ± 2%, and the ratio of monomer to dimer
resulted in an estimated dissociation constant KD for the monomer–dimer equilibrium of 25 ± 15 mM.
(ii) In 50 mM NaCl, monomeric C4b gave s20,w values of 8.38 ± 0.14 and 8.41 ± 0.15 S for the absorbance and
interference data, respectively (Figure 5B,D). The s20,w values have therefore increased by 0.36–0.45 S,
showing that C4b had formed a more compact structure in low NaCl concentration buffer. This s20,w change
is similar to the difference seen for the s20,w value for C3b of 7.40 S in 137 mM NaCl, which increased to
7.60 S in 50 mM NaCl [10]. The difference in s20,w values between 50 and 137 mM NaCl is greater than the
expected precision of these measurements of ±0.1 S determined from measurements on 79 different AUC
instruments [41], although it is noted that all measurements here were made on the same AUC instrument.
The molecular masses from the c(s) peaks corresponded to 185 kDa, which agreed well with the expected
value. The presumed dimeric peak observed at 11.5 ± 0.4 S has a molecular mass that corresponded to
323 kDa. The mean s20,w value of the presumed dimer was also increased in 50 mM NaCl compared with
that of 11.0 S in 137 mM NaCl, also indicating that the dimer was more compact in shape in low salt. The
percentage of dimer was now larger in 50 mM NaCl at 12 ± 1%, and the ratio of monomer to dimer gave an
estimated KD value for the monomer–dimer equilibrium of 20 ± 15 mM. The s20,w value of the C4b dimer
peak was similar to that of 11.8 and 12.1 S calculated for the back-to-back dimer seen in one of the C3b
crystal structures (PDB ID: 2WIN) [9], suggesting that this was indeed a C4b dimer.
SAXS analyses of C4b in solution
SAXS is a diffraction technique used to study the overall structure of biological molecules in random orienta-
tions in solution [16]. Thus, SAXS data enabled the structural conformation of C4b to be studied in solution.
The scattering data I(Q) were collected at C4b concentrations between 0.6 and 1.2 mg/ml for C4b in three
Figure 5. Sedimentation velocity experiments with C4b in 50 and 137 mM NaCl.
(A and B) The interference boundary ﬁts (left) and the corresponding c(s) distributions (right) are shown for C4b in 137 and
50 mM NaCl buffers. For clarity, only every sixth boundary of the 130 that were recorded are shown. (C and D) The absorbance
boundaries ﬁts (left) and the corresponding c(s) distributions (right) are shown for C4b in 137 and 50 mM NaCl buffers. For
clarity, only every sixth boundary of the 130 boundaries are shown. M, monomer; D, dimer.
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NaCl buffers (50, 137 and 250 mM) to match the DPI experiments. No radiation damage effects were
observed.
(i) Guinier analyses at low Q ranges in the scattering curves gave RG values that monitored the overall structure
of C4b and its degree of elongation in different NaCl concentrations. The Q ranges used to ﬁt the Guinier
plots resulted in linear plots from which the RG ﬁts were obtained. The mean RG values for C4b in 137 and
250 mM NaCl were identical at 4.89 ± 0.06 and 4.90 ± 0.02 nm, respectively (Figure 6B,C). Despite the detec-
tion of dimer by AUC, the effect of dimer on the RG ﬁts was minimised by performing these ﬁts in larger Q
ranges with a Q·RG range from 1.0 upwards. Dimer would feature most strongly at the lowest Q values. In
50 mM NaCl, a slight upturn in the I(Q) intensities at the lowest Q values now reﬂected the presence of 12%
dimers that was observed in the AUC analyses (Figure 6A). For this reason, the RG ﬁts were performed in a
larger Q range than for the two other NaCl concentrations. An RG value of 4.94 ± 0.02 nm was estimated,
and this is an average of the RG values of the C4b monomer and dimer mixture. If the C4b dimer has an RG
value signiﬁcantly in excess of 4.9 nm, as expected from the AUC analyses above, the RG value of the C4b
monomer will be less than the RG values of 4.89–4.90 nm for C4b measured in 137 and 250 mM NaCl. This
reasoning shows that C4b will be more compact in shape in 50 mM NaCl.
(ii) The distance distribution function P(r) curves were calculated from the full scattering curves and represent all
the distances between pairs of atoms within C4b (Figure 6). The P(r) function also provided an alternative deter-
mination of the RG values. These RG values were 5.03 ± 0.07 and 5.04 ± 0.05 nm for 137 and 250 mM NaCl,
respectively, in agreement with the Guinier analyses. The maximum length L of C4b was determined from the
value of r when P(r) = 0. L was found to be 16.5 nm for 137 mM NaCl and 17 nm for 250 mM NaCl, which are
comparable with the dimensions of 15 nm× 8.5 nm seen with the C4b crystal structure (Figure 1A).
Atomistic scattering modelling of C4b in solution
The recent crystal structure of C4b revealed that the TED and MG1 domains were connected by an Arg104–
Glu1032 salt bridge to form a compact structure (Figure 1A) [3]. Because the DPI, AUC and SAXS data sets
Figure 6. Guinier RG and distance distribution function P(r) analyses for C4b.
In the X-ray Guinier plots for C4b (upper panels), the ﬁt ranges used to determine the RG values are denoted by ﬁlled circles,
together with satisfactory Q·RG ranges as labelled. Panels A, B and C correspond to buffers containing 50 mM NaCl, 137 mM
NaCl and 250 mM NaCl respectively. The Q ranges used for ﬁts were 0.21–0.30 nm−1 for 50 mM NaCl and 0.18–0.30 nm−1 for
137 mM and 250 mM NaCl. The C4b concentrations were 0.6, 0.8, 1.0 and 1.2 mg/ml for 50 mM and 137 mM NaCl, and 0.6,
0.8 and 1.2 mg/ml for 250 mM NaCl.
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each indicated the existence of compact and extended structures in 50 and 137–250 mM NaCl buffers, respect-
ively, a new atomistic modelling procedure based on 21 000 physically realistic trial structures was applied to
model the structure of C4b from its scattering curve in 137–250 mM NaCl [17]. The modelling of C4b in
50 mM NaCl was precluded by the presence of C4b dimers. Previously, 4650 structurally randomised models
derived from the crystal structure of C3b were used to ﬁt the scattering curves of C3b and C3u in 50 and
137 mM NaCl buffers, to reveal compact and extended conformations, respectively, in these buffers [9,10].
Starting from the C4b crystal structure, this new modelling located the TED and CUB domains by variations
in the linker peptides between the TED and CUB domains with 7–10 amino acid residues in each (Figure 1C).
Linkers 1 and 2 were each conformationally sampled in three different searches to create the 21 000 C4b models.
The ﬁrst search created 10 000 possible conformations by moving the rigid TED–CUB domain pair (Materials
and Methods). The second search created 2000 conformations by moving TED alone. The third search took the
best-ﬁt C4b model from the ﬁrst search and created 9000 conformations by moving TED alone. The curve ﬁts
of the models against the experimental curves gave 21 000 goodness-of-ﬁt R-factors that were compared with the
RG values of these C4b models to result in a single well-deﬁned minimum (green and orange, Figure 7). Visual
inspection showed that a single family of conformers gave good ﬁts to the experimental SAXS curves in both
137 and 250 mM NaCl. The 100 lowest R-factors corresponded to models with RG values within error of the
experimental RG values. For 137 mM NaCl, the best-ﬁt 10 models gave R-factors of 4.35–4.39%, and the best-ﬁt
100 models showed R-factors up to 4.50%. For 250 mM NaCl, the best-ﬁt 10 models gave R-factors of 3.92–
3.94%, and the best-ﬁt 100 models showed R-factors up to 4.00%. In contrast, the C4b crystal structure with the
compact TED–MG1 structure (Figure 1A) gave worsened R-factors of 5.6 and 4.7% for the two curves, indicat-
ing that this structure did not correspond well to the solution structure of C4b.
Comparisons of the experimental and modelled scattering curves showed that excellent curve ﬁts were
obtained, especially at low and high Q (Figure 8A,B). The best R-factors were 4.35 and 3.94% in 137 and
250 mM NaCl buffers, respectively, in which the reduced second value may reﬂect a further reduction in the
C4b dimers in higher salt. The C4b models had been created without the addition of biantennary complex-type
N-glycan chains. These glycans were added to Asn207, Asn843, Asn1309 and Asn1372 in the best-ﬁt C4b
models in extended conformations [22,23]. The effect on the R-factors was minimal and did not affect the con-
clusions of this study. Comparisons of the experimental C4b scattering curve in 137 mM NaCl with the C4b
Figure 7. Atomistic scattering modelling analyses of the C4b solution structure.
The X-ray R-factors for 21,000 conformational models of C4b in which Linkers 1 and 2 were varied (Figure 1) are compared
with their RG values. Panels A and B correspond to buffers containing 137 mM NaCl and 250 mM NaCl respectively. The
vertical line corresponds to the experimental RG values, with RG error ranges of ±5% denoted by dashed lines. The ten, 100
and 700 best ﬁt models from the 21,000 conformations are denoted in orange, green and dark green respectively. The ﬁt for
the C4b crystal structure is denoted by the cyan circle at a lower RG value.
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crystal structure showed slight but visible differences both at low Q and high Q (Figure 8C). The P(r) curves
also showed differences in large r values. The discrepancy at low Q corresponds to different RG values between
the crystal and solution structures, whereas that at high Q corresponds to the different interdomain separations
between the TED–CUB pair and the MG1–MG8 core. These differences were readily explained by the separ-
ation of the TED and MG1 domains in solution, which were in contact with each other in the crystal structure.
As a further test, the s20,w value of the 10 best-ﬁt C4b solution models and the C4b crystal structure were calcu-
lated using HYDROPRO. The 10 best-ﬁt C4b models in 137 mM NaCl gave s20,w values of 7.85–7.90 S, which
were lower than that of 8.08 S for the C4b crystal structure with the more compact domain arrangement, as
expected (Table 1). The 10 best-ﬁt models gave better agreement with the experimental AUC value of 7.97 ±
0.08 S than the crystal structure.
Figure 8. X-ray curve ﬁts for the C4b crystal structure and best-ﬁt solution structures.
The experimental I(Q) and P(r) scattering curves for C4b are shown in black. The theoretical ﬁtted curves are shown in red.
(A and B) The comparison of the best-ﬁt C4b solution structure with the X-ray scattering curves in 137 and 250 mM NaCl are
shown, with R-factors of 4.3 and 3.9%, respectively (Table 1). (C) The comparison of the C4b crystal structure with the X-ray
scattering curve of C4b in 137 mM NaCl is shown, giving an R-factor of 5.6% (cyan, Figure 7).
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The outcome of the C4b conformational searches was now evaluated. To assess the C4b conformations gener-
ated in the 21 000 models, the distances between the centres of mass of TED and the MG1 domain were moni-
tored. This histogram showed that the most common distance was ∼5.5 nm and the frequency of the larger
distances decreases above 8 nm up to 15 nm (Figure 9A). To establish that no conformational variation in the
best-ﬁt models had been overlooked, the top 100 models were compared with the top 700 models. For the
137 mM NaCl ﬁts, the 700 best-ﬁt models showed that the most common TED–MG1 separation is 4.7 ± 0.1 nm
and no model showed a distance over 5.7 nm (Figure 9B). A similar outcome resulted with the 100 best-ﬁt
models with a separation of 4.7 ± 0.1 nm. For the 250 mM NaCl ﬁts, the most common distance was again 4.8 ±
0.1 nm and again no model showed a distance over 5.7 nm (Figure 9C). The superimposition of the 10 best-ﬁt
C4b models in 137 and 250 mM NaCl showed that these were structurally similar to each other (Figure 10A,B).
Three-dimensional density plots showed that the 21 000 C4b models generated in the conformational search had
sampled all orientations, shown as a black outline grid in Figure 10C,D. In conﬁrmation of the modelling
searches, the 700 best-ﬁt models occupied a limited distribution of positions. This distribution was further con-
tracted when only the 100 best-ﬁt models were considered. All these best-ﬁt models showed that TED and the
MG1 domain were close to each other, but not in actual contact with each other, meaning that the Arg104–
Glu1032 salt bridge has ruptured. In conﬁrmation of this result, these modelled separations of 4.7–4.8 nm were
larger than that of 4.0 nm seen in the compact C4b crystal structure (PDB ID: 4XAM) [3]. The corresponding
TED–MG1 separations in four C3b crystal structures were within error of this at 3.8 ± 0.4 nm [9,10].
Discussion
The present study showed that the extended and compact structures in C4b play a major role on the overall
conformation of C4b, which in turn affects its molecular mechanism for its function and its regulatory control.
C4b was shown to be more compact in 50 mM NaCl, when the TED and MG1 domain are in contact with
each other through salt-bridge formation. C4b was more extended in physiological 137 mM NaCl buffer, which
prevails in serum, when the salt-bridge interaction is broken. Importantly, using a combination of a sensor
Table 1 X-ray scattering and sedimentation coefficient modelling fits for C4b
Filter
Number of
models RG (nm)
1
R-factor
(%)
Length L
(nm) s20,w (S)
C4b (50 mM NaCl) Experimental 4.94 ± 0.02
5.01 ± 0.032
16.0 8.38 ± 0.14
C4b (137 mM NaCl) None 21 000 4.08–5.44 4.3–12.7 n.a n.a.
R-factor 700 4.66–4.89 4.3–4.8 n.a n.a
100 4.71–4.88 4.3–4.5 n.a n.a
Top 10 fits 10 4.78–4.81 4.3–4.4 16–16.5 7.85–7.90
Best fit 1 4.78 4.3 16.5 7.90
Experimental 4.89 ± 0.02
5.03 ± 0.07
16.5 7.97 ± 0.08
C4b (250 mM NaCl) None 21 000 4.08–5.44 3.9–12.6 n.a n.a.
R-factor 700 4.64–4.88 3.9–4.3 n.a n.a
100 4.68–4.82 3.9–4.3
Top 10 fits 10 4.76–4.81 3.9–3.9 16–17 7.90–8.01
Best fit 1 4.81 3.9 16.5 7.95
Experimental 4.90 ± 0.02
5.04 ± 0.05
17.0 n.a
1The first experimental RG value is from the Guinier analyses; the second experimental RG value is from the P(r) analyses.
2The experimental RG values in 50 mM NaCl were affected by up to 12% dimer formation and were not used further, although the s20,w value was
unaffected by this (Results).
n.a. means not available.
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surface technology (DPI) and two solution technologies (AUC and SAXS), we showed that this conformational
change occurred both at surfaces and in solution. The extent of the conformational change was large enough to
be detected by DPI and AUC, and by SAXS only in 137–250 mM NaCl, and its magnitude was determined by
DPI and by a new atomistic SAXS modelling method (Figure 10A,B). The results for C4b concur with our
earlier NaCl concentration solution studies of complement C3b and C3u of the alternative pathway of comple-
ment activation, which showed the same result [9,10]. Both C4b and C3b share the same 12-domain structure.
However, C4 and C4b are important in relation to only the classical and lectin activation pathways, whereas C3
and C3b are centrally important for complement function as well as functioning in the alternative pathway of
activation. A BLAST alignment comparison showed that C4b shared a 30.4% sequence identity with C3b, and
their molecular masses were 5% different at 188.0 and 179.3 kDa, respectively. Despite these differences, for the
ﬁrst time, we show that the same ionic strength-mediated conformational change occurs in both C4b and C3b.
This conformational change inC4b andC3b is important for both the regulatory control of complement activation
and in disease mechanisms. Crystallographic studies have clariﬁed how ﬁve complement regulators bind to active
C3b. These C3b complexes include as ligands Factor H short complement regulator domains (SCR) 1/4, membrane
cofactor protein (MCP) SCR-3/4, complement receptor type 1 SCR-15/17, decay acceleration factor SCR-2/4 and
variola virus SPICE SCR-1/4 [42,43]. All ﬁve crystal structures showed that the complexes between C3b and its SCR
regulator involve contacts between theMG2 domain in C3b and the ﬁrst SCR domain of the SCR pair, together with
contacts betweenTEDand the secondSCRdomainof thepair (Figure10E).Thus, complex formationwith the regula-
torcanonlyoccur if theTED–CUBdomainpair is in the closed conformation seen in lowsalt. TheArg102–Glu1032 salt
bridge in C3b and the Arg104–Glu1032 salt bridge in C4b help to stabilise this complex [42,43]. The importance of the
Figure 9. Histograms of the best-ﬁt C4b conformational models.
(A–C) The three histograms summarise the distribution of the separations between the centres of mass of the TED and MG1
domains in the modelling ﬁts. First, that for all 21 000 conformational models is shown. Next, the histograms for the 700
best-ﬁt models in 137 mM NaCl buffer (dark green in Figure 7A), with the 100 best-ﬁt models shown in the inset (light green in
Figure 7A). The broken line indicates the average TED–MG1 separation of 4.7 nm. Finally, the corresponding histograms for the
700 and 100 best-ﬁt models for 250 mM NaCl buffer from Figure 7B are shown.
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Arg102–Glu1032 salt bridge was demonstrated by mutagenesis experiments involving Glu1032 in TED [10]. Under
physiological conditions in plasma, our data showed that the TED–CUBdomain pair will be extended away from the
MG core of C4b and C3b, and thus unable to form the regulatory complex. Interestingly, this conformational differ-
ence between a fully reactive extended C4b or C3b structurewith an exposed thioester bridge in the ﬂuid phase and a
compact regulated C4b or C3b structure provides ameans of altering the reactivity of C4b or C3b to a less active form
when either is bound to its regulator. The efﬁciency of C3b binding to activator surfaces is affected by the location of
TED inC3b [44]. Only solution structural studies have been able to reveal this outcome; the extended structure is pre-
sumed tobe tooﬂexible to crystallise.
In terms of complement-mediated disease, even though C4b and C3b are functional and structurally related, and
while C4 deﬁciency is linked to autoimmune disease and systemic lupus erythematosus [45], we are not aware of
any diseases associated with a C4b missense mutation involving the Arg104–Glu1032 salt bridge in C4b. We note that
another salt bridge also exists between Glu1357 and Arg974 in C4b between the CUB and MG2 domains. MCP is
another of the main regulators of C4b and C3b akin to Factor H and serves to inactivate C4b and C3b bound to
host cell surfaces [46]. Sequence alignment showed that the residues that affected C4b binding to MCP, such as
V1155, are also present in C3b. It can be assumed that mutations that affect C4b binding to MCP might also
perturb C3b binding with MCP, as revealed by the recent crystal structure of C3b with MCP [42]. Thus, other inter-
actions between the TED–CUB domains and the MG1–MG8 domains in C4b may play a role in disease, although
these will relate more closely to the complement regulators than with C4b itself. The well-characterised Arg102–
Glu1032 salt bridge is crucial for C3b and the Factor H SCR-1/4 domains [47]. The C3b polymorphism R102G that
affects the Arg102–Glu1032 bridge is linked to AMD and aHUS [10]. Several other C3b mutations are genetically
Figure 10. The best-ﬁt C4b conformational models and their functional implication.
(A and B) The 10 best-ﬁt C4b solution structures that ﬁtted the X-ray scattering curves in 137 and 250 mM NaCl are shown.
The α, β and γ chains of C4b are shown in green, cyan and pink, respectively (Figure 1A). The MG core structures were
superimposed upon each other to show the variation in position of the 10 TED–CUB domain pairs. (C and D) The best-ﬁt C4b
solution structures are represented as density plots. The grey outline grid shows the boundary of the 21 000 TED and CUB
locations in the C4b conformational models. The location of the TED and CUB domains in (C) the 700 best-ﬁt and (D) 100
best-ﬁt structures for the ﬁts in 137 mM NaCl are shown as cyan envelopes to follow the colour scheme of Figure 1A. Within
this envelope, the best-ﬁt C4b solution structure is shown as a ribbon. (E) The crystal structure of C4b was superimposed on
the crystal structure of the complex between C3b and MCP SCR-3/4. For reason of clarity, the orientation was rotated by 180°
about a vertical axis compared with that of Figure 1A. Inset: The Arg104–Glu1032 salt bridge between TED (cyan) and the MG1
domain (green) is highlighted to show its importance in the regulatory breakdown of C4b by its cofactors.
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associated with aHUS [48,49]. One of these mutations (I1157T) is thought to involve the TED–MG1 separation and
reduces C3b binding to MCP and in turn reduces its C3b cleavage by the serine protease factor I [48].
The methods reported here provide a new approach to investigating the ﬂexibility of the major complement
proteins C4b and C3b, initially based on a multidisciplinary experimental approach, and followed by advanced
SAXS modelling based on the generation and testing of thousands of physically realistic structures [17].
(i) Three sets of experimental data showed that the conformational change of C4b between low and high salt
had occurred. By DPI, the immobilisation of C4b via its free thiol group in the thioester bond is analogous
to its physiological binding to surfaces during complement activation. Our use of DPI revealed increased
thickness changes of up to 0.46 nm in the immobilised C4b surface layer on increase in the NaCl concentra-
tion (Figure 4). By AUC, it was possible to identify C4b monomer and dimer (Figure 5), as witnessed previ-
ously [50], and monomeric C4b sedimented more slowly by 0.4 S in physiological salt compared with low
salt (Table 1). Similar slower sedimentation rates were likewise seen for C3b and C3u in physiological buffer.
C3, C3b and C3u underwent dimer self-association of 3, 2 and 8%, respectively, in 137 mM NaCl buffer
[9,10], which compares well with that of 5% for C4b. However, C4b unexpectedly formed 12% C4b dimer in
50 mM NaCl; the corresponding amount of C3b dimer was 4%. This higher dimer level for C4b clariﬁed
that SAXS could not be used to monitor the C4b solution structure in detail in low salt, thus illustrating the
value of our multidisciplinary approach. By SAXS, the RG value of C4b was found to be 4.89 ± 0.02 nm in
137 mM NaCl, which was similar to that for C3b of 4.90 ± 0.02 nm.
(ii) Our new SAXS modelling extends the original small-sphere modelling of C4, C4u and C4b from X-ray and
neutron scattering data [51]. In the absence of any known crystal structures at that time, that early study had
reported a two-segmented elongated structure in C4b, i.e. the separate TED–CUB domains and the MG1–
MG8 core were already detectable at that time. Presently, the atomistic scattering modelling of C4b from the
data obtained in 137 and 250 mM NaCl provided solution structural information on extended structures for
C4b, in distinction to the compact C4b structure seen using crystals grown in 0.4 M MgCl2 [3]. This
compact conformation for C4b is attributable to crystal packing considerations, which favoured this arrange-
ment during crystal growth, and illustrates the need for approaches to verify the actual solution structure. For
C4b, good curve ﬁts starting from known crystal structures were similar to those for other complement pro-
teins [16]. For C4b here, the best R-factor values were 4.3 and 3.9% for 137 and 250 mM NaCl, respectively
(Table 1). For C3b previously, the best R-factor values from 4650 trial conformational models were similar at
2.8 and 2.2%, respectively, for 50 and 137 mM NaCl [10]. The main advantages of the present atomistic
SASSIE modelling for C4b, compared with previous with C3b, were the rapid generation of a four-fold
increase in the number of C4b models for curve ﬁts, using Monte Carlo variations of dihedral angles, and
the better handling of steric overlaps where C4b models show these clashes were discarded at their creation.
In addition, the use of force-ﬁeld representations for the 21 000 C4b models mean that the resulting struc-
tures were physically reasonable and offer further insights on the conformation of C4b.
In conclusion, an ensemble of 100 best-ﬁt C4b structures (Supplementary Material) from the SASSIE analyses
was determined to represent the C4b solution structure (Figure 10D). These structures permitted an assessment
of the conformational changes in C4b. The C4b modelling in 137 and 250 mM NaCl resulted in a best-ﬁt
TED–MG1 separation of 4.7 ± 0.1 nm (Figures 9 and 10). These separations were larger than that of 4.0 nm
seen in the compact C4b crystal structure (PDB ID: 4XAM) [3]. These ﬁtted dimensions for the best-ﬁt C4b
solution structure account not only for the outcomes of the AUC and SAXS solution analyses, but also the
surface analyses from DPI which reported a thickness change of 0.46 nm. This detail of atomistic modelling is
advantageous by determining a numerical separation for 100 and 700 best-ﬁt C4b structures, which is improved
compared with a simple rigid body modelling approach that only ﬁtted four possible C4b conformations for
scattering curves measured in a single 100 mM NaCl buffer [3]. Previously, 4–10 best-ﬁt C3b structures were
determined in our former and less precise curve modelling analysis. From these, the ﬁtted TED–MG1 separa-
tions in C3b were 4.3 ± 0.4 nm (50 mM NaCl) and 5.2 ± 0.5 nm (137 mM NaCl). The value of 4.3 nm agreed
with the separation of 3.8 ± 0.4 nm seen in four C3b crystal structures, indicating that both structures showed
compact TED–MG1 arrangements (PDB ID: 2I07, 2WIN, 2WII and 2ICF) [5,10]. Thus, both C4b and C3b
underwent similar conformational changes with changes in NaCl concentration. This joint experimental and
computational approach complements previous methods used to study multidomain protein conformations
and their ﬂexibility, and is expected to have high potential in the future. Importantly, they are performed in
solution under physiological conditions.
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